Tuberculosis Resource Centre | Clinical | MDR | Research| CME | Viatris

Tuberculosis Resource Centre | Clinical | MDR | Research| CME | Viatris
Tuberculosis Resource Centre | Clinical | MDR | Research| CME | Viatris

About TB resource center:

Tuberculosis CMEs: Together till End Tb, as per the context of this page, our goal is to create awareness amongst healthcare professionals (HCPs) through continuing medical education (CMEs) activities to enable them to eliminate TB and improve quality of patient care. This Tuberculosis clinical resource center, is dedicated to bringing the latest CMEs and experience sharing events for healthcare professionals on topics related to guidelines, protocols, methods for early diagnosis, treatment and management of tuberculosis (TB) and multidrug-resistant (MDR) TB, research and innovations. The strategy envisions a world free of TB.

Who should attend/ take the course?:

We welcome all healthcare providers who interact with TB patients to join these programs (General Physicians, Specialists, Pulmonologists, TB Officers, Nurses, Pharmacists etc) to enhance their awareness of this complex disease and its management. Events on this page are supported by Mylan Pharmaceuticals Pvt. Ltd.- a Viatris company.

Access all Tuberculosis CMEs during 2022: 

During the year 2022, Medical Learning Hub (MLH) conducted several online courses, CMEs and medical webinars to help HCPs navigate through the complex topic of TB diagnosis, treatment and management. These topics included: 

MDR TB & Comorbidities:

MDR TB & Comorbidities by Dr Kinjal D Modi, Dr. Vishnu Sharma M. Multidrug-resistant TB (MDR TB) is caused by tuberculosis bacteria that show resistance to at least isoniazid and rifampin, the drugs used to treat patients with TB. During this course, the speakers presented about recent advances in diagnosis & management of pulmonary & Extra Pulmonary Tuberculosis and presented patient case in TB & EPTB. The discussions were related to Microscopy, Cultures, NAAT, Marked effects of NAAT, Xpert in EPTB, Role of serodiagnosis, IGRA’s and TB diagnosis-future trends. Click here to access this webinar on MDR TB Comorbidities

TB, HIV & other comorbidities:  

Human Immunodeficiency Virus (HIV) is a virus that weakens the immune system. People who are living with HIV are much more likely to become sick with the opportunistic tuberculosis (TB) infection, because of their weaker immune system. During this webinar, Dr. Digambar Behera, Dr. K P Singh, Dr. Kuldeep Singh Sachdeva and Dr. Narendran Gopalan discuss the challenges and an integrated approach to its clinical management. Click here to access the course on comorbidities in TB.